Resources

Selected
  • COVID-19
Type of publications
Regions
Diseases
Methodological quality (AMSTAR 2)
1481 results found
2023 ∙ Tayebi, A. Samimisedeh, P. Jafari Afshar, E. Mahmoudnia, S. Milan, N. Ayati, A. Madady, A. Rastad, H.
Neuromuscular diseases associated with COVID-19 vaccines: a systematic review and pooled analysis of 258 patients
Adults Older adults COVID-19 Safety
Rating:
Critically low
2023 ∙ Potestio, L. Battista, T. Cacciapuoti, S. Ruggiero, A. Martora, F. Fornaro, L. Camela, E. Megna, M.
New Onset and Exacerbation of Psoriasis Following COVID-19 Vaccination: A Review of the Current Knowledge
Adults Older adults COVID-19 Safety
Rating:
Critically low
2023 ∙ Harel, T. Gorman, E. F. Wallin, M. T.
New onset or relapsing neuromyelitis optica temporally associated with SARS-CoV-2 infection and COVID-19 vaccination: a systematic review
Adolescents Adults Older adults COVID-19 Safety
Rating:
Critically low
2023 ∙ Arifin, A. N. F. Hengky, A. Widjaja, M. Wijaya, L.
New-Onset and Exacerbation of Psoriasis following COVID-19 Vaccination: A Systematic Review of Case Reports and Case Series
Adults Older adults COVID-19 Safety
Rating:
Critically low
2023 ∙ Liu, J. Wu, H. Xia, S. L.
New-Onset Arthritis Following COVID-19 Vaccination: A Systematic Review of Case Reports
Adults Older adults COVID-19 Safety
Rating:
Critically low
2023 ∙ Nune, A. Durkowski, V. Pillay, S. S. Barman, B. Elwell, H. Bora, K. Bilgrami, S. Mahmood, S. Babajan, N. Venkatachalam, S. Ottewell, L. Manzo, C.
New-Onset Rheumatic Immune-Mediated Inflammatory Diseases Following SARS-CoV-2 Vaccinations until May 2023: A Systematic Review
Adults Older adults COVID-19 Safety
Rating:
Critically low
2023 ∙ Puspitasari, M. Sattwika, P. D. Rahari, D. S. Wijaya, W. Hidayat, A. R. P. Kertia, N. Purwanto, B. Thobari, J. A.
Outcomes of vaccinations against respiratory diseases in patients with end-stage renal disease undergoing hemodialysis: A systematic review and meta-analysis
All age groups COVID-19 Efficacy/effectiveness Safety
Rating:
Critically low
2023 ∙ Ishisaka, Y. Watanabe, A. Aikawa, T. Kanaoka, K. Takagi, H. Wiley, J. Yasuhara, J. Kuno, T.
Overview of SARS-CoV-2 infection and vaccine associated myocarditis compared to non-COVID-19-associated myocarditis: A systematic review and meta-analysis
All age groups COVID-19 Safety
Rating:
Critically low
2023 ∙ Yong, S. J. Halim, A. Liu, S. Halim, M. Alshehri, A. A. Alshahrani, M. A. Alshahrani, M. M. Alfaraj, A. H. Alburaiky, L. M. Khamis, F. Muzaheed, None AlShehail, B. M. Alfaresi, M. Al Azmi, R. Albayat, H. Al Kaabi, N. A. Alhajri, M. Al Amri, K. A. S. Alsalman, J. Algosaibi, S. A. Al Fares, M. A. Almanaa, T. N. Almutawif, Y. A. Mohapatra, R. K. Rabaan, A. A.
Pooled rates and demographics of POTS following SARS-CoV-2 infection versus COVID-19 vaccination: Systematic review and meta-analysis
Adults COVID-19 Safety
Rating:
Low
2023 ∙ Samimisedeh, P. Jafari Afshar, E. Tayebi, A. Rastad, H.
Post-acute midterm follow-up cardiac MRI findings and clinical outcomes in patients with COVID-19 vaccine-associated myocarditis: a comprehensive systematic review and meta-analysis
Adolescents Adults COVID-19 Safety
Rating:
Critically low
Loading...